Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: The AIDA open label, randomized, controlled Phase 4 trial

BACKGROUND: The need for oral, cost-effective treatment for complicated skin and skin structure infections (cSSSIs) due to methicillin-resistant Staphylococcus aureus (MRSA) was addressed by the non-inferiority comparisons of oral minocycline plus rifampicin with linezolid. METHODS: In the AIDA mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotsaki, Antigone, Tziolos, Nikolaos, Kontopoulou, Theano, Koutelidakis, Ioannis M., Symbardi, Styliani, Reed, Vaughan, O'Hare, Miriam, Alexiou, Zoi, Sambatakou, Helen, Toutouzas, Konstantinos, Akinosoglou, Karolina, Lada, Malvina, Giamarellos-Bourboulis, Evangelos J., MacGowan, Alasdair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813692/
https://www.ncbi.nlm.nih.gov/pubmed/36618892
http://dx.doi.org/10.1016/j.eclinm.2022.101790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813692/
https://www.ncbi.nlm.nih.gov/pubmed/36618892
http://dx.doi.org/10.1016/j.eclinm.2022.101790

Ejemplares similares